1. Recurrent esophageal carcinoma after esophagectomy with three-field lymph node dissection
- Author
-
Hoichi Kato, Hiroshi Watanabe, Hiroyasu Igaki, Atsushi Ochiai, Yuji Tachimori, and Yukihiro Nakanishi
- Subjects
Male ,medicine.medical_specialty ,Esophageal Neoplasms ,medicine.medical_treatment ,Recurrent Esophageal Carcinoma ,Recurrence ,Carcinoma ,Humans ,Medicine ,Neoplasm Metastasis ,Esophagus ,Lymph node ,Survival rate ,Aged ,business.industry ,Esophageal disease ,General Medicine ,Middle Aged ,medicine.disease ,Surgery ,Esophagectomy ,Survival Rate ,medicine.anatomical_structure ,Oncology ,Lymphatic Metastasis ,Carcinoma, Squamous Cell ,Lymph Node Excision ,Female ,Lymphadenectomy ,Lymph Nodes ,business - Abstract
To evaluate the effect of the extended lymphadenectomy for thoracic esophageal carcinoma, the pattern of recurrence in the 50 patients with pT3 tumors who underwent esophagectomy with cervical, mediastinal, and abdominal lymph node dissection (3-F) (group A) was compared with that of 100 patients at pT3 who underwent esophagectomy without upper mediastinal and cervical lymphadenectomy (2-F) (group B). The cumulative 5-year survival rate for 115 patients who underwent 3-F was 50.9%. Cumulative 5-year survival rates for patients in groups A and B were 36.8% and 22.0%, respectively. The survival curve for group A was significantly better than group B (P = 0.02332). Lymphatic recurrence was noted less frequently in group A (8/23) than in group B (31/49) (χ2 = 5.1149), whereas the rate of hematogenous recurrence was similar. Extension of the field of lymph node dissection reduced the lymph node recurrence in patients with thoracic esophageal carcinoma, which may have positively affected patient survival. © 1996 Wiley-Liss, Inc.
- Published
- 1996